Fighting Childhood Brain Cancer Together in Honor of Emily Hood
After believing Emily had suffered a concussion during a wrestling match, just a week after her 17th birthday, we found out that it was DIPG, the most deadly, incurable form of brain cancer in children. She immediately took charge of her treatments, believing that God had a plan for her, and did he ever as she continuously shared her faith as she went through her journey. She took part in many different kinds of therapies, enduring a month and a half total of radiation with several different versions of chemotherapy. When the Brain Child 03 clinical trial opened up at Seattle Children’s Hospital, Emily became the first patient with DIPG to receive CAR T cells targeting B7-H3 AND the first patient with DIPG to receive intracranial CAR T cells. We are so proud of her incredible acts of bravery and selflessness; she is and will forever be our hero. Private funding for research is essential to finding a cure for DIPG and our family is committed to continuing Emily’s legacy of giving by supporting brain cancer research and families currently in treatment.